Zobrazeno 1 - 10
of 47
pro vyhledávání: '"C. H. van Gils"'
Autor:
M. A. A. Ragusi, B. H. M. van der Velden, M. C. van Maaren, E. van der Wall, C. H. van Gils, R. M. Pijnappel, K. G. A. Gilhuijs, S. G. Elias
Publikováno v:
Breast Cancer Research and Treatment, 193(1), 161-173
Breast Cancer Research and Treatment 193 (2022) 1
Breast cancer research and treatment, 193(1), 161-173. Springer
Breast Cancer Research and Treatment 193 (2022) 1
Breast cancer research and treatment, 193(1), 161-173. Springer
Purpose Although adjuvant systemic therapy (AST) helps increase breast cancer-specific survival (BCSS), there is a growing concern for overtreatment. By estimating the expected BCSS of AST using PREDICT, this study aims to quantify the number of pati
Autor:
Arjen J. Witkamp, M. Sier, Wiesje Maarse, M.L. Gregorowitsch, C. H. van Gils, T. van Dalen, H.J.G.D. Van den Bongard, A. Doeksen, Helena M. Verkooijen, Marilot C T Batenburg, A. Braakenburg, Danny A. Young-Afat, E J P Schoenmaeckers
Publikováno v:
Breast Cancer Research and Treatment
Purpose To evaluate patient-reported cosmetic satisfaction in women treated with radiation therapy for breast cancer and to determine the association between dissatisfaction and quality of life (QoL) and depression. Methods Within the prospective UMB
Autor:
Katie M. O'Brien, W.-P. Koh, Elisabete Weiderpass, T E Rohan, Kimberly A. Bertrand, Walter C. Willett, J.-M. Yuan, H. O. Adami, Timothy J. Key, Victoria A. Kirsh, M. C. Boutron-Ruault, M. Dorronsoro, Giovanna Masala, RL Milne, Antonia Trichopoulou, Rudolph Kaaks, Dale P. Sandler, Atsuko Sadakane, E. Riboli, Susan E. Hankinson, Minouk J. Schoemaker, Linet, Laure Dossus, Anthony J. Swerdlow, AH Eliassen, Michael Jones, Hazel B. Nichols, Mark N. Brook, Laura Baglietto, Leslie R. Bernstein, Huiyan Ma, Melissa A. Merritt, Malin Sund, Rulla M. Tamimi, Susanna C. Larsson, LB Wright, Cari M. Kitahara, Alicja Wolk, G.G. Giles, Avonne E. Connor, Kotaro Ozasa, Anne Zeleniuch-Jacquotte, Yunn-Yi Chen, C. H. van Gils, Inger T. Gram, Julie R. Palmer, Giske Ursin, Kim Overvad, K Visvanathan
Publikováno v:
Cancer Research. 79:P1-08
This abstract was withdrawn by the authors. Citation Format: Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami H-O, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault M-C, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliass
Autor:
Arjen J. Witkamp, Alexander H. R. Varey, C. H. van Gils, Richard A. Scolyer, Serigne Lo, P. J. Van Diest, John F. Thompson, Vigfús Sigurdsson, M A El Sharouni, Tasnia Ahmed
Publikováno v:
The British journal of dermatologyReferences. 185(2)
Background A nomogram to predict sentinel node (SN) positivity [the Melanoma Institute Australia (MIA) nomogram] was recently developed and externally validated using two large single-institution databases. However, there remains a need to further va
Autor:
Serigne Lo, P. J. Van Diest, John F. Thompson, Karijn P M Suijkerbuijk, Anne E. Cust, M.D. Stodell, Vigfús Sigurdsson, Richard A. Scolyer, M A El Sharouni, C. H. van Gils, Arjen J. Witkamp, Tasnia Ahmed
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 32(3)
Background It has been claimed, without supporting evidence, that knowledge of sentinel node (SN) status does not provide more accurate prognostic information than basic clinicopathological features of a primary cutaneous melanoma. We sought to inves
Autor:
R. Tumino, Marco Matejcic, J. R. Quirós, Anne Zeleniuch-Jacquotte, Marc J. Gunter, Björn Gylling, Elisabete Weiderpass, Pagona Lagiou, Genevieve Buckland, Salvatore Panico, Flavie Perrier, C. Ricci, Renée T. Fortner, Fulvio Ricceri, Pilar Amiano, Inge Huybrechts, Veronique Chajes, Mathilde His, Claire Cadeau, Petra H.M. Peeters, Isabelle Romieu, M-D Chirlaque, Timothy J. Key, Vassiliki Benetou, Antonia Trichopoulou, David G. Cox, Elio Riboli, M. C. Boutron-Ruault, Rudolf Kaaks, Sabina Sieri, D. Palli, María José Sánchez, Aurelio Barricarte, Carine Biessy, H. Bas Bueno-de-Mesquita, J. D. De Batlle, H. Boeing, C. H. van Gils, Guri Skeie
Publikováno v:
International Journal of Cancer. 140:1246-1259
Epidemiological studies have reported inconsistent findings for the association between B vitamins and breast cancer (BC) risk. We investigated the relationship between biomarkers of folate and vit ...
Autor:
Evelyn M. Monninkhof, G. C. W. Wendel-Vos, Helena M. Verkooijen, P. H. M. Peeters, Roxanne Gal, C. H. van Gils, Nicolaas P.A. Zuithoff, D. Van den Bongard, A. M. May
Publikováno v:
Acta Oncologica, 58(5), 673. Informa Healthcare
Acta oncologica (Stockholm, Sweden), 58(5), 673-681. Informa Healthcare
Acta oncologica (Stockholm, Sweden), 58(5), 673-681. Informa Healthcare
Background: Physical activity has been shown to reduce side-effects of breast cancer and its treatment. As physical activity levels of patients with breast cancer are largely unknown, we investigated these levels and compared them to women from the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43887cfc68090773186756d2e697c638
Autor:
A. M. May, Helena M. Verkooijen, D. Van den Bongard, M. van Vulpen, C. H. van Gils, D. Young Afat
Publikováno v:
Cancer Research. 76:P5-18
Introduction: The randomized controlled trial (RCT) is the gold standard for evaluation of effectiveness of new interventions. In oncology, however, RCTs are often complicated by logistic challenges, slow recruitment, limited generalisability, and st
Autor:
M. van Vulpen, Arjen J. Witkamp, Helena M. Verkooijen, I Burgmans, Danny A. Young-Afat, D. Van den Bongard, M.L. Gregorowitsch, C. H. van Gils, Yvette Jonasse, C. C. van der Pol
Publikováno v:
Cancer Research. 76:P3-12
PURPOSE/OBJECTIVE Innovations in loco-regional breast cancer treatment, such as oncoplastic surgery and neoadjuvant chemotherapy, have been suggested to increase the risk of breast and chest wall edema, which may impair quality of life (QoL) during a
Autor:
Danny A. Young-Afat, J.P. Pignol, C. H. van Gils, D. Van den Bongard, M.L. Gregorowitsch, M. van Vulpen, Helena M. Verkooijen
Publikováno v:
Cancer Research. 76:P4-11
INTRODUCTION Patients with ductal carcinoma in situ (DCIS) have excellent overall survival rates. Yet, previous studies suggested that quality of life (QoL) between patients with DCIS and patients with early-invasive breast cancer (early-IBC) are sim